News Daily News FDA Approval of Cangrelor Expands Antiplatelet Options for PCI Todd Neale June 29, 2015
News Daily News ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS Todd Neale June 22, 2015
News Daily News Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone L.A. McKeown April 28, 2015
News Daily News Registry Data Suggest Net Clinical Benefit From Pretreating STEMI Patients With Clopidogrel Todd Neale February 05, 2015
News Daily News Outcomes Do Not Suffer With Shortened Eptifibatide Infusion During PCI Todd Neale January 28, 2015
News Daily News Los Resultados No Sufren con Infusiones Más Cortas de Eptifibatide durante la realización de PCI Todd Neale January 28, 2015
News Daily News NSTE-ACS Patients With Inflammation Gain the Most Kidney Protection From Statin Pretreatment Yael L. Maxwell December 15, 2014
News Conference News AHA 2014 Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel Yael L. Maxwell November 17, 2014
News Daily News Meta-analysis: No Need for Thienopyridine Loading Dose in NSTE-ACS Patients Caitlin E. Cox November 17, 2014
News Daily News Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI Todd Neale August 20, 2014
News Daily News In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors L.A. McKeown August 20, 2014
News Daily News Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI Yael L. Maxwell May 01, 2014